This is a revised application for support of a predoctoral training program in Virology at the University of Minnesota. The specific need for a training grant in the area of Virology has arisen from the efforts of an energetic and dynamic group of University of Minnesota faculty, who are all members of the Institute for Molecular Virology (IMV). The primary goal of this training grant application is to attract and educate predoctoral students with an interest in pursuing an independent research career. The 12 preceptors involved in this training program represent a highly enthusiastic mixture of senior and more junior faculty members that are strongly committed to the training of predoctoral students in Virology. All of the participating preceptors have trained and graduated at least 1 Ph.D. student and all have current federal grant support for their research programs. Several of the preceptors are accomplished leaders in their research areas, while others are rising stars. The overarching research theme of the training program is virus-host cell interactions, which encompasses 1) mechanisms of viral replication and restriction and 2) molecular pathogenesis. Predoctoral students who seek training in Virology enroll in the Microbiology, Immunology and Cancer Biology (MlCaB) Graduate Program or the Molecular, Cellular and Structural Biology (MCSB) Graduate Program. Students will take graduate level courses in cell and molecular biology and obtain rigorous and intensive coursework in Virology. Predoctoral students will be chosen for this training program from a pool of MICaB and MCSB students, typically in their second or third year of training, by a competitive selection process. Students will be supported for up to 3 years. Students supported by the training program will participate in IMV research-in-progress meetings, IMV subgroup meetings, a virology journal club, an IMV lecture series, and the annual IMV Symposium. Trainees are expected to complete their dissertation research in 4-5 years, publish their work in high-profile virology journals, and pursue postdoctoral training at leading research institutions.
This training program is relevant to public health as it supports career development of young scientists who will help develop new antiviral drugs and vaccines for viral diseases.
|Schwartz, John C; Murtaugh, Michael P (2014) Characterization of a polymorphic IGLV gene in pigs (Sus scrofa). Immunogenetics 66:507-11|
|Tschida, Barbara R; Largaespada, David A; Keng, Vincent W (2014) Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies. Semin Cell Dev Biol 27:86-95|
|Rawson, Jonathan M O; Mansky, Louis M (2014) Retroviral vectors for analysis of viral mutagenesis and recombination. Viruses 6:3612-42|
|Murtaugh, Michael P (2014) Advances in swine immunology help move vaccine technology forward. Vet Immunol Immunopathol 159:202-7|
|Rawson, Jonathan M; Heineman, Richard H; Beach, Lauren B et al. (2013) 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors. Bioorg Med Chem 21:7222-8|
|Burns, Michael B; Lackey, Lela; Carpenter, Michael A et al. (2013) APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494:366-70|
|Dawson, Harry D; Loveland, Jane E; Pascal, Geraldine et al. (2013) Structural and functional annotation of the porcine immunome. BMC Genomics 14:332|
|Land, Allison M; Law, Emily K; Carpenter, Michael A et al. (2013) Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic. J Biol Chem 288:17253-60|
|Lackey, Lela; Law, Emily K; Brown, William L et al. (2013) Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination. Cell Cycle 12:762-72|
|Lackey, Lela; Demorest, Zachary L; Land, Allison M et al. (2012) APOBEC3B and AID have similar nuclear import mechanisms. J Mol Biol 419:301-14|
Showing the most recent 10 out of 11 publications